QLT announces positive results from the evaluation of Visudyne(R) combination therapy
... to lower light doses being used in this study. After treatment, patients should avoid direct sunlight for five days to prevent sunburn. People with porphyria should not be treated with Visudyne. About QLT QLT Inc. is a global biopharmaceutical company dedicated to the discovery, development and ...QLT announces interim results of radical study evaluating Visudyne combination therapy
... to lower light doses being used in this study. After treatment, patients should avoid direct sunlight for five days to prevent sunburn. People with porphyria should not be treated with Visudyne. About QLT QLT Inc. is a global biopharmaceutical company dedicated to the discovery, ...New book by UCR biologist discusses 12 diseases that impacted humanity
... book , Sherman argues that the following dozen diseases shaped history and illuminated the paths taken in finding measures to control them: porphyria and hemophilia , which influenced the political fortunes of England, Germany, Russia and the United States Late blight , which spawned a wave ...Study Unveils New Insight To The Madness Of King George III
... journal Cell that the nutritional component of porphyria involves a key master metabolic molecule, PGC-1 ... III’s hair contained arsenic, which can provoke porphyria attacks. PGC-1 alpha is a “transcriptional ... The findings suggest that patients with porphyria should avoid any drugs or foods that turn on ...ABCB6 Is Key to Production of Heme in Hemoglobin
... triggers pain in the chest, abdomen, limbs or back, as well as paralysis, cramping and personality changes or mental disorders. 'Also, people with porphyria can suffer sudden, acute attacks if they take certain tranquilizers and other drugs that interfere with this system,' Schuetz said. 'So our work ...Colour Of Urine Can Reveal The Health Status Of The Patients
... And gout can produce pink urine. This diagnostic tool goes back many centuries. The ancient Greeks first diagnosed the rare blood disorder porphyria by observing colourful urine and even named the illness after the Greek word for purple. Then in the Middle Ages, when urine analysis enjoyed ...Arsenic May Have Been Responsible For The Madness Of King George III Of England
... contamination of his antimonial medications is the probable source of the arsenic. We propose that exposure to arsenic would exacerbate attacks of porphyria in a genetically predisposed individual. King George III was diagnosed to have suffered from Porphyria- a genetic defect leading to the faulty ...AMT Receives EMEA Orphan Drug Designation for Acute Intermittent Porphyria
... AMT-021 for the treatment of acute intermittent porphyria (AIP). Orphan Drug Designation for AIP ... disease." About Acute Intermittent porphyria Acute intermittent porphyria is a rare genetic disease in which mutations in ...Acute Intermittent Porphyria Enzyme
Description: ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' ...Attacks of King George III's madness linked to key metabolism molecule
... mediates effects of nutrition on blood disease porphyria Dana-Farber Cancer Institute researchers say ... issue of Cell that the nutritional component of porphyria involves a key master metabolic molecule, PGC-1 ... PhD, is lead author. "We've explained how porphyria symptoms can occur in episodic attacks triggered ...ABCB6 is key to production of heme in hemoglobin
... triggers pain in the chest, abdomen, limbs or back, as well as paralysis, cramping and personality changes or mental disorders. "Also, people with porphyria can suffer sudden, acute attacks if they take certain tranquilizers and other drugs that interfere with this system," Schuetz said. "So our work ...Amsterdam Molecular Therapeutics Reports Full Year Results 2007
... trial in Canada on track - Appointment of Ferdinand Verdonck as chairman of supervisory board. - Global rights for acute intermittent porphyria treatment - Exclusive license to all gene therapy products from CIMA - Agreement with CIMA/Digna Biotech for AAV-mediated IGF-I treatment of late ...Amsterdam Molecular Therapeutics Reports Half Year Results 2007
... Appointment of Ferdinand Verdonck as chairman of supervisory board. - Global rights for our product AMT 020 for the treatment of acute intermittent porphyria Results comparison Total revenues for the six months ended June 30, 2007, were EUR 50,000 compared to EUR 208,000 for the same period in 2006. The ...